Skip to content

Clinical trials

Terminated Phase 2/3 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Australia Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20084
20091
20111
20132
20142
20155
20163
20172
20181
20194
20205
20212
20226
20234
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Novartis Pharmaceuticals3
Bristol-Myers Squibb2
Facet Biotech2
Gilead Sciences2
Janssen Research & Development, LLC2
PTC Therapeutics2
Theravance Biopharma2
ACADIA Pharmaceuticals Inc.1
AN2 Therapeutics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative6
Alzheimer Disease5
Dementia3
Inflammatory Bowel Diseases3
Cholangiocarcinoma2
Crohn Disease2
Heart Failure2
Acute Kidney Injury1
Adenoviridae Infections1
Angina Pectoris1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.